Minnetronix Medical Names Jeremy Maniak President and CEO

ST. PAUL, Minn.–(BUSINESS WIRE)–Minnetronix Medical, Inc., a leading medical technology company, today announced that the company’s President, Jeremy Maniak, will succeed founder Richard Nazarian as CEO on February 1, 2020. Maniak has held several positions at Minnetronix since joining the firm in 2010 and will continue Minnetronix’ mission to positively impact the lives of patients through medical technology.

Nazarian founded Minnetronix in 1996 along with fellow 3M veterans Dirk Smith and Jon Pierce and the company has since grown to employ over 300 people and generate annual revenues of over $100M.

“I’m proud of what we’ve achieved over the past 23 years, but we’ve only scratched the surface of what this company is capable of,” said Nazarian. “Jeremy is just the right person at just the right time to build an enduring Minnetronix for years to come. I’m excited to see him take Minnetronix to even greater success.”

Maniak is a nine-year veteran of Minnetronix and was named COO in 2013. He is an experienced innovator and strategist with a background from Guidant (Boston Scientific) and Leptos Medical. Maniak has helped advance Minnetronix’ product, technology and service solutions in support of consistent double-digit growth and a rapidly evolving neuro interventional product portfolio. “Minnetronix has come a long way since its founding and Rich has positioned us really well for growth and innovation long into the future. I am excited and honored to work with this exceptional Minnetronix team that is so dedicated to positively impacting our customers and patients,” said Maniak.

Maniak will report to and join the company’s board of directors with Nazarian continuing as its Chairman.

About Minnetronix Medical

Minnetronix Medical develops technology, service and product solutions for medical device companies and patients across the globe. The company focuses on four key vertical markets: patient centered devices, fluidics, energy-based instruments and treatments, and optical systems. www.minnetronixmedical.com

Contacts

Carolyn Baldus

cbaldus@minnetronixmedical.com
612.296.3338

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC – Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE…

2 hours ago

1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth

VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / 1933 Industries Inc. (the "Company"…

2 hours ago

Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims

Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business…

5 hours ago

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

11 hours ago

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive…

11 hours ago

Therap Services Announces 2026 National Conference Schedule: Highlighting New Tools, Best Practices, and Over 250 Specialized Sessions

TORRINGTON, Conn., Dec. 17, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

11 hours ago